GlassScriptPhysician profile
Barry M Schulman
NPI 1720081078
$3,349.54
in general payments reported to CMS, 2019-2025
20 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $651 · 2020: $113 · 2021: $588 · 2022: $922 · 2023: $219 · 2024: $532 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,893.33 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Organogenesis INC. | $602.47 | 2019-2025 | Puraply Wound Matrix |
| Amgen INC. | $124.99 | 2024 | Krystexxa |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Kerecis Limited | $85.68 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $81.79 | 2019-2023 | Nuzyra |
| Epsfl, LLC | $81.00 | 2023 | |
| Medartis INC. | $52.36 | 2019-2020 | |
| Cardiovascular Systems INC. | $52.03 | 2019 | |
| Terumo Medical Corporation | $45.34 | 2019 | |
| Horizon Therapeutics Plc | $44.35 | 2019 | |
| Abbvie INC. | $30.82 | 2021-2023 | Dalvance |
| Djo, LLC | $26.78 | 2025 | Cmf |
| Wright Medical Technology, INC. | $26.58 | 2019 | |
| Orthofix Medical, INC. | $25.05 | 2021-2024 | Physio-Stim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $21.54 | 2019 | |
| Averitas Pharma INC. | $18.17 | 2023 | Qutenza |
| Medtronic, INC. | $17.72 | 2024 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $15.70 | 2019 | |
| Nevro Corp. | $14.01 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Schulman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.